Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00650
|
|||||
| Drug Name |
Reboxetine
|
|||||
| Synonyms |
(+-)-(2R*)-2-((alphaR*)-alpha-(o-Ethoxyphenoxy)benzyl)morpholine; (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; (2R)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; (2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; 2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate; 2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine; Davedax; Davedax (TN); Edronax; Edronax (TN); Esreboxetine; Esreboxetine (USAN/INN); Norebox; Norebox (TN); Prolift; Prolift (TN); Reboxetine (INN); Reboxetine [INN]; Reboxetine mesylate; Reboxitine; Solvex; Solvex (TN); Vestra; Vestra (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antidepressants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H23NO3
|
|||||
| Canonical SMILES |
CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3
|
|||||
| InChI |
InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1
|
|||||
| InChIKey |
CBQGYUDMJHNJBX-RTBURBONSA-N
|
|||||
| CAS Number |
CAS 71620-89-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 313.4 | Topological Polar Surface Area | 39.7 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.